Abstract: This invention relates to a pharmaceutical composition for use as a direct compression tableting agent containing carbonyl iron and a process for making the same.

Abstract: A medicament consisting of a biological medium-soluble capsule containing a micronised progesterone suspended in oil is disclosed, characterised in that the capsule also contains estradiol enclosed in microspheres, also suspended in oil, and which consist of one or more polymers that do not dissolve in oil but that dissolve in a biological medium.

Abstract: A method is provided for preparing drug formulations suitable for electrotransport drug delivery. The drug to be delivered, present in salt form, is contacted with an ion exchange material prior to incorporation into the reservoir (26) of an electrotransport delivery system (10). In this way, the drug salt is partially or completely neutralized. This technique is useful for adjusting the pH of the drug formulation without incorporating extraneous materials, e.g., competing ions or the like, into the reservoir (26).

Abstract: Cross-linked hydrogels comprise a variety of biologic and non-biologic polymers, such as proteins, polysaccharides, and synthetic polymers. Such hydrogels preferably have no free aqueous phase and may be applied to target sites in a patient's body by extruding the hydrogel through an orifice at the target site. Alternatively, the hydrogels may be mechanically disrupted and used in implantable articles, such as breast implants. When used in vivo, the compositions are useful for controlled release drug delivery, for inhibiting post-surgical spinal and other tissue adhesions, for filling tissue divots, tissue tracts, body cavities, surgical defects, and the like.

Abstract: Injection formulations of avermectins and milbemycins based on castor oil are disclosed.

Abstract: A method of applying a layer-form active ingredient depot with delayed release of active ingredients to plants or plant parts, having at least one pressure-sensitively adhering matrix layer (A) which comprises active ingredient and is in two-dimensional contact with the plant surface, and one back layer (B) which is essentially free from and impermeable to active ingredient and is on the side remote from the plant is characterized in that the layer (A) is produced by painting in the desired two-dimensional pattern at the site of application on the plant from a spreadable, pressure-sensitively adhering, polymer-based composition which comprises active ingredient and then on the said layer (A) the layer (B) is produced by painting or spraying.

Abstract: The invention describes a protein extract in the form of an alcoholic extraction solution obtained from dried cereal gluten, which solution has been treated with glycerol and/or a short-chain alkanediol and evaporated under reduced pressure until the alcohol content is less than 5% by weight, preferably less than 1% by weight.This extract is outstandingly suitable for use in cosmetic preparations for care of damaged hair.

Abstract: Pharmaceutical compositions in topical or parenteral form containing specific organic mono- or dinitrates, some of them novel compounds, are effective in treating male impotence and erectile dysfunction through topical or intracavernosal administration to the penis. Methods of treatment utilizing the mono- or dinitrate-containing compositions are also disclosed.

Abstract: The analgesic effectiveness of an analgesic selected from the group consisting of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine, (S)-5-(2-azetidinylmethoxy)-2-chloropyridine and pharmaceutically acceptable salts thereof is significantly potentiated by administering an analgesic-potentiating amount for said analgesic of at least one nontoxic NMDA receptor antagonist.

Abstract: The present invention is related to a new analgesic composition of acetaminophen targeting decreasing of liver toxicity and releasing of hangover, which comprises aspartic acid promoting alcohol metabolism and methionine alleviating liver toxicity of acetaminophen. The analgesic combination preparation according to the present invention showed same analgesic and excellent protection effect against liver toxicity compared with the single preparation of acetaminophen, and decreased the blood concentration of alcohol and acetaldehyde causing hangover through improving metabolism rates of them. The combination preparation according to the present invention, therefore, is coincident with ideal new analgesic composition of acetaminophen having a minimized side effect and a hangover releasing effect.

Abstract: The present invention relates to cosmetic or pharmaceutical compositions comprising a powder containing a water soluble carboxylated gum and a clay crosslinked with metal ions.

Abstract: A urea-containing component of a skin care agent or skin preparation, wherein the urea forms inclusion compounds with fatty acids and/or fatty acid compounds, so that fat is made available for skin care which is protected against oxidation. A method of manufacturing the urea-containing component of a skin care agent includes cooking an oil or a mixture of fatty acid ethyl esters manufactured from an oil with urea in a solvent in a non-oxidizing atmosphere until the urea has been dissolved, permitting the mixture to cool, and finally cooling the mixture to a final temperature of below 10.degree. C. and separating the resulting precipitate.

Abstract: Gluconolactone or glucarolactone in cosmetic skin care compositions, as anti-irritants, to reduce skin irritation, which may be intrinsic skin irritation or irritation caused by hydroxy acids or certain retinoids.

Abstract: A process for preventing precipitates in fresh pressed echinacea plant juice comprising cooling the fresh pressed plant juice obtained for a short time, followed by filtration and stabilisation by the addition of acid. The pressed plant juice is preferably cooled to temperatures between 0 and -15.degree. C. for less than 14 days and after filtration adjusted to a pH value below 6 by adding 0.01 to 5% of a polyvalent carboxylic acid, preferably citric acid.

Abstract: Levobupivacaine or ropavicaine is used to treat migraine.

Abstract: A vasodilator delivery system is provided for producing and maintaining the erection of a male penis during intercourse. The vasodilator is contained in a transdermal patch. The transdermal patch comprises a thin, smooth-edged layered structure for dispensing a suitable vasodilator to the penis skin surface. In each embodiment of the patch, a vasodilator is applied to the skin of the user and is sealed against unwanted contraindicated leakage and contact with the internal tissues of a sex partner.

Abstract: The present invention provides a core of predominately microcrystalline cellulose, on which an active drug is layered onto the core via solution coating. The coated particles have a narrower particle size distribution than coated granules provided by other processes. An optional final coating of a pharmaceutically acceptable polymeric coating is provided to provide tastemaking or controlled release, and protection of the drug-layered particles.

Abstract: A hair conditioning shampoo composition containing: (a) a quaternary ammonium component; (b) an emulsifier component; (c) an amphoteric surfactant component; (d) an alkyl polyglycoside of formula I:R.sub.1 O(R.sub.2 O).sub.b (Z).sub.a Iwherein R.sub.1 is a monovalent organic radical having from about 6 to about 30 carbon atoms; R.sub.2 is a divalent alkylene radical having from 2 to 4 carbon atoms; Z is a saccharide residue having 5 or 6 carbon atoms; b is a number having a value from 0 to about 12; a is a number having a value from 1 to about 6; (e) an emollient component; (f) water; (g) an anionic surfactant component; (h) an amide component; and (i) an electrolyte component.

Abstract: The present invention provides improved perming agents and perming methods which can minimize damage to hair and simplify perming processes simultaneously and also can relieve a pain of a subject to be permed by shortening time required for a perming operation. The present invention uses a perming agent containing 2-7% of one kind or more than two kinds of mercaptan selected from thioglycolic acid, salt of thioglycolic acid, cysteine and acetyl cysteine and 1.5-17.5% of one or more than two kinds of disulfide selected from dithiodiglycolic acid, salt of dithiodiglycolic acid and cysteine, with a mixing ratio of disulfide to mercaptan being 0.75-2.5 to induce simultaneous progression of oxidation and reduction and, when necessary, in combination with a second agent containing an oxidizing agent for giving permanent wave to hair or curing wavy hair.

Abstract: A pharmaceutical preparation, and treatment method using the same, for contact dermatitis and particularly for canine contact dermatitis. The preparation has as active ingredients an anti-histamine and an anti-inflammatory. The anti-histamine is preferably diphenhydramine. The anti-inflammatory is preferably triamcinolone. The preparation is a liquid mixture and is sprayed or otherwise applied onto an affected area.